The world’s biggest clinical study on the immune effects of probiotics prove that RESITON could reduce the duration of the symptoms of the common cold and flu.
L. paracasei subsp. paracasei CRL 431 induced an immunologic response that provided enhanced protection of cells from virus infections by 2 to 6 times more. Various clinical studies prove that Resiton (L. paracasei subsp. paracasei) helps body to fight against infections including flu and influenza viruses1,2,3.
Published in The American Journal of Clinical Nutrition, April 29, 2015 researchers investigated the effect of the probiotic RESITON strain Lactobacillus paracasei subsp. paracasei on immune responses to influenza (flu) vaccination and respiratory symptoms involving 1,104 subjects in a randomized, double-blind, placebo¬-controlled, parallel-group study. Findings from the Chr. Hansen backed trail showed that RESITON (L. paracasei subsp. paracasei) can shorten the duration of common cold and influenza¬ like illnesses, and could lower the use of health care resources and reduce the use of antibiotics4.
Results from the study indicate that in cases of flu¬like illnesses, the number of sick days was reduced by 37.5%, five days in the group that consumed daily 1 billion live bacteria, compared to eight days in the placebo group. Mikkel Jungersen, scientific advisor for Human Health & Nutrition at Chr. Hansen said that, not only this is a clear benefit for individuals. It also indicates that products with this probiotic strain can have a significant impact on productivity in society4.
For further information please write to us or visit our website www.maknsons.net or consult your doctor.
References:
1. Lillian Jespersen, et al. Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. The American Journal of Clinical Nutrition, April 29, 2015
2. Giuliano Rizzardinia, et al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition. September 07, 2011.
3. de Vrese M, et al. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. European Journal of Nutrition. 2005 Oct; 44(7):406-13.
4. Nathan Gray, Nutra Ingredients, May 21, ¬2015.
